Tissue Recovery Research Kit
BPC-157 (10mg) & TB-500 (10mg) Combination Kit
The Tissue Recovery Research Kit pairs two mechanistically complementary lyophilized peptides—pentadecapeptide BPC-157 (VEGFR2/Akt-eNOS modulation) and 43-residue Thymosin β4 sequence TB-500 (G-actin sequestration)—with USP-grade 0.9% Benzyl Alcohol Bacteriostatic Water. Every peptide vial is released at ≥99.0% purity via RP-HPLC and ESI-MS.
Included Components
- BPC-157 10mg Lyophilized Vial (≥99% HPLC)
- TB-500 10mg Lyophilized Vial (≥99% HPLC)
- Bacteriostatic Water 10ml USP (0.9% Benzyl Alcohol)
Combined in-vitro research protocol evaluating fibroblast migration, focal adhesion kinase (FAK) phosphorylation, nitric oxide synthase signaling, and globular actin filament remodeling across dermal and tendon cell models.
Store lyophilized vials at -20°C; store Bacteriostatic Water at 15°C–25°C. Refrigerate reconstituted solutions at 2°C–8°C for up to 28 days.
Analytical & Stoichiometric Notes
Supplied as separate single-compound vials rather than a pre-blended cake so researchers can independently titrate molar ratios (BPC-157 MW 1419.53 g/mol vs. TB-500 MW 4963.50 g/mol) and verify distinct RP-HPLC retention profiles.
Laboratory Kit Preparation Workflow
- 1 Equilibrate sealed lyophilized vials to room temperature (20°C–25°C) inside a desiccator for 15 minutes before septum disinfection.
- 2 Reconstitute BPC-157 (10 mg) and TB-500 (10 mg) separately using the included USP 0.9% Benzyl Alcohol Bacteriostatic Water (e.g., 2.0 mL per vial for 5.0 mg/mL stock).
- 3 Roll each vial gently along the glass wall until optically clear—never vortex the 43-residue TB-500 polypeptide.
- 4 Label reconstituted stocks with date and lot number, refrigerate at 2°C–8°C, and aliquot prior to assay dilution.
Individual Constituent Specifications
Tissue Recovery Research Kit — Technical FAQ
Why does this kit supply BPC-157 and TB-500 in separate vials instead of a single blend?
Separate vials allow independent concentration control and prevent unintended cross-interaction or pH drift between a 15-residue gastric pentadecapeptide and a 43-residue acetylated Thymosin β4 chain during long-term bench storage.
What molarity is achieved when reconstituting each 10 mg vial in 2.0 mL of BAC water?
A 5.0 mg/mL stock equals ~3.52 mM for BPC-157 (MW 1419.53 g/mol) and ~1.01 mM for TB-500 (MW 4963.50 g/mol) prior to batch Net Peptide Content (NPC) adjustment.